No Data
No Data
Express News | China Merchants Securities downgraded the rating of Pharmaceutical Kangde H shares to holding, with a target price of HK$38.
J.P. Morgan sold 640,200 H shares of Yao Ming Kangde (02359.HK), worth approximately HK$22.394,900
On May 2, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 2, JPMorgan Chase & Co. (JPMorgan Chase & Co.) sold $640,200 H-share shares worth approximately HK$22.394 million on April 26 at an average price of HK$34.9789 per share and an average OTC share price of HK$34.9502. After the sale, J.P. Morgan Chase's latest shareholding was 34.278 million shares, and the good position ratio dropped from 9.02% to 8.85%. Image source: Stock Exchange equity disclosure What is equity
Yao Ming Kangde (02359.HK) received 304,800 H shares from J.P. Morgan Chase, worth approximately HK$10.361 million
On May 2, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 2, JPMorgan Chase & Co. (JPMorgan Chase & Co.) increased its holdings of $33.994 per share on the market and HK$33.9942 per share on the market to a total of HK$33.9942 per share, totaling HK$304,800 in H shares, worth approximately HK$10.361 million. After the increase in holdings, J.P. Morgan Chase's latest shareholding was 349.18,200 shares, and the good position ratio increased from 8.94% to 9.02%. Image source: Stock Exchange equity disclosure What is equity
Hong Kong stocks started “booming” in May! The Hang Seng Index reclaimed the 18,000 mark, and in April, Demon Stock added another 30% assist
On May 2, Hong Kong stocks ushered in the first trading day of May, and the three major stock indexes continued their major counterattack!
Hong Kong biotechnology stocks continued to strengthen. Cornerstone Pharmaceuticals rose nearly 23%, Gacos rose more than 14%, Cansino Biotech rose nearly 14%, Lepu Biotech rose more than 10%, and Pharmacom Kangde rose nearly 8.5%.
Hong Kong biotechnology stocks continued to strengthen. Cornerstone Pharmaceuticals rose nearly 23%, Gacos rose more than 14%, Cansino Biotech rose nearly 14%, Lepu Biotech rose more than 10%, and Pharmacom Kangde rose nearly 8.5%.
WUXI APPTEC(603259):STEADY 1Q PERFORMANCE AMID CHALLENGING ENVIRONMENT
WuXi AppTec reported 1Q24 revenue of RMB7,982mn, down 11.0% YoY, attributable re
No Data